Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -942 | -1,646 | -2,882 | 512 | -10,777 |
| Depreciation Amortization | 1 | 1 | 48 | 77 | 72 |
| Other Working Capital | -1,293 | 692 | 853 | 1,934 | 455 |
| Other Operating Activity | 546 | 0 | -503 | -5,474 | 2,189 |
| Operating Cash Flow | $-1,687 | $-952 | $-2,485 | $-2,951 | $-8,060 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 1 | N/A | N/A |
| Sale Of Investment | 884 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 300 | 35 | 77 |
| Investing Cash Flow | $884 | $N/A | $301 | $35 | $77 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 725 | 510 | 2,240 | 3,310 | 1,350 |
| Debt Repayment | N/A | N/A | -1 | -603 | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 2,000 |
| Other Financing Activity | 175 | 323 | -18 | -8 | 4,875 |
| Financing Cash Flow | $900 | $833 | $2,221 | $2,699 | $8,225 |
| Beginning Cash Position | 17 | 136 | 99 | 315 | 74 |
| End Cash Position | 114 | 17 | 136 | 99 | 315 |
| Net Cash Flow | $97 | $-119 | $37 | $-217 | $241 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,687 | -952 | -2,485 | -2,951 | -8,060 |
| Capital Expenditure | N/A | N/A | -2 | N/A | N/A |
| Free Cash Flow | -1,687 | -952 | -2,487 | -2,951 | -8,060 |